Inventor · disambiguated record
Yun-Long Li
Also filed as: LI YUN · LI YUN XIN · LI YUN-LONG · QIAO JENNIFER X
106 granted patents·28 pending applications·1,910 citations·filing 2002–2025
99Inventor score
Files withINCYTE CORP88LI YUN-LONG11BRISTOL MYERS SQUIBB CO6HONGFUJIN PREC IND SHENZHEN6HON HAI PREC IND CO LTD5
Top patents by PatentIndex Score
134 records- 0199US9623029B23-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl]octane- or heptane-nitrile as JAK inhibitorsINCYTE CORP·Filed 2015·Granted Apr 18, 2017·44 cites·11 claims
- 0299US9181271B2Tricyclic fused thiophene derivatives as JAK inhibitorsINCYTE CORP·Filed 2013·Granted Nov 10, 2015·105 cites·6 claims
- 0399US8604043B23-[4-(7H-pyrrolo[2,3-D]pyrimidin-4-yl)-1H-pyrazol-1-yl]octane- or heptane-nitrile as jak inhibitorsLI YUN-LONG·Filed 2010·Granted Dec 10, 2013·117 cites·20 claims
- 0498US10435392B2Bipyrazole derivatives as JAK inhibitorsINCYTE CORP·Filed 2018·Granted Oct 8, 2019·18 cites·28 claims
- 0598US10376513B2Heterocyclylamines as PI3K inhibitorsINCYTE CORP·Filed 2018·Granted Aug 13, 2019·12 cites·21 claims
- 0698US9216984B23-[4-(7H-pyrrolo[2,3-D]pyrimidin-4-yl)-1H-pyrazol-1-yl]octane—or heptane-nitrile as JAK inhibitorsINCYTE CORP·Filed 2013·Granted Dec 22, 2015·56 cites·26 claims
- 0798US9199982B2Heterocyclylamines as PI3K inhibitorsLI YUN-LONG·Filed 2012·Granted Dec 1, 2015·52 cites·15 claims
- 0898US8940752B2Pyrimidinones as PI3K inhibitorsLI YUN-LONG·Filed 2010·Granted Jan 27, 2015·62 cites·16 claims
- 0998US8309718B24-pyrazolyl-N-arylpyrimidin-2-amines and 4-pyrazolyl-N-heteroarylpyrimidin-2-amines as janus kinase inhibitorsLI YUN-LONG·Filed 2008·Granted Nov 13, 2012·109 cites·35 claims
- 1097US11591318B2Bipyrazole derivatives as JAK inhibitorsINCYTE CORP·Filed 2021·Granted Feb 28, 2023·6 cites·19 claims
- 1197US11591338B2Pyrrolotriazine compounds as TAM inhibitorsINCYTE CORP·Filed 2020·Granted Feb 28, 2023·5 cites·4 claims
- 1297US11401280B2Pyrimidinones as PI3K inhibitorsINCYTE CORP·Filed 2020·Granted Aug 2, 2022·4 cites·32 claims
- 1397US11001571B2Bipyrazole derivatives as JAK inhibitorsINCYTE CORP·Filed 2019·Granted May 11, 2021·15 cites·16 claims
- 1497US10844069B2Pyrrolotriazine compounds as TAM inhibitorsINCYTE CORP·Filed 2019·Granted Nov 24, 2020·9 cites·19 claims
- 1597US10442810B2Pyrrolotriazine compounds as TAM inhibitorsINCYTE CORP·Filed 2018·Granted Oct 15, 2019·12 cites·25 claims
- 1697US10125150B2Crystalline forms of a PI3K inhibitorINCYTE CORP·Filed 2018·Granted Nov 13, 2018·15 cites·31 claims
- 1797US10092570B2Heterocyclylamines as PI3K inhibitorsINCYTE CORP·Filed 2017·Granted Oct 9, 2018·17 cites·20 claims
- 1897US10077277B2Bicyclic heteroarylaminoalkyl phenyl derivatives as PI3K inhibitorsINCYTE CORP·Filed 2015·Granted Sep 18, 2018·22 cites·24 claims
- 1997US9988401B2Crystalline forms of a PI3K inhibitorINCYTE CORP·Filed 2016·Granted Jun 5, 2018·14 cites·27 claims
- 2097US9981975B2Pyrrolotriazine compounds as tam inhibitorsINCYTE CORP·Filed 2017·Granted May 29, 2018·18 cites·4 claims
- 2197US9730939B2Heterocyclylamines as PI3K inhibitorsINCYTE CORP·Filed 2015·Granted Aug 15, 2017·23 cites·7 claims
- 2297US9707233B2Heterocyclylamines as PI3K inhibitorsINCYTE CORP·Filed 2015·Granted Jul 18, 2017·23 cites·21 claims
- 2397US9708333B2Fused bicyclic 1,2,4-triazine compounds as TAM inhibitorsINCYTE CORP·Filed 2016·Granted Jul 18, 2017·19 cites·14 claims
- 2497US9540347B2Pyridineamine compounds useful as Pim kinase inhibitorsINCYTE CORP·Filed 2016·Granted Jan 10, 2017·19 cites·70 claims
- 2597US9434746B2Pyrimidinones as PI3K inhibitorsINCYTE CORP·Filed 2014·Granted Sep 6, 2016·32 cites·25 claims
- 2697US9382231B2Bipyrazole derivatives as JAK inhibitorsINCYTE CORP·Filed 2014·Granted Jul 5, 2016·40 cites·30 claims
- 2797US9096600B2N-(1-(substituted-phenyl)ethyl)-9H-purin-6-amines as PI3K inhibitorsLI YUN-LONG·Filed 2011·Granted Aug 4, 2015·47 cites·28 claims
- 2897US8759359B2Substituted heteroaryl fused derivatives as PI3K inhibitorsCOMBS ANDREW P·Filed 2010·Granted Jun 24, 2014·64 cites·25 claims
- 2997US8461330B2Imidazotriazines and imidazopyrimidines as kinase inhibitorsZHUO JINCONG·Filed 2010·Granted Jun 11, 2013·40 cites·25 claims
- 3097US6989391B2Lactam-containing compounds and derivatives thereof as factor Xa inhibitorsBRISTOL MYERS SQUIBB PHARMA CO·Filed 2004·Granted Jan 24, 2006·59 cites·35 claims
- 3196US9926301B2Bipyrazole derivatives as JAK inhibitorsINCYTE CORP·Filed 2016·Granted Mar 27, 2018·18 cites·37 claims
- 3296US9815839B2N-(1-(substituted-phenyl)ethyl)-9H-purin-6-amines as PI3K inhibitorsINCYTE CORP·Filed 2016·Granted Nov 14, 2017·20 cites·16 claims
- 3396US9802918B2Pyridineamine compounds useful as Pim kinase inhibitorsINCYTE CORP·Filed 2016·Granted Oct 31, 2017·13 cites·16 claims
- 3496US9580418B2Bicyclic aromatic carboxamide compounds useful as Pim kinase inhibitorsINCYTE CORP·Filed 2015·Granted Feb 28, 2017·19 cites·64 claims
- 3596US9550765B2Thiazolecarboxamides and pyridinecarboxamide compounds useful as Pim kinase inhibitorsINCYTE CORP·Filed 2015·Granted Jan 24, 2017·19 cites·56 claims
- 3696US9527848B2N-(1-(substituted-phenyl)ethyl)-9H-purin-6-amines as PI3K inhibitorsINCYTE CORP·Filed 2015·Granted Dec 27, 2016·25 cites·12 claims
- 3796US9249145B2Heterocyclic derivatives of pyrazol-4-yl-pyrrolo[2,3-d]pyrimidines as janus kinase inhibitorsRODGERS JAMES D·Filed 2010·Granted Feb 2, 2016·45 cites·56 claims
- 3896US9200004B2Thiazolecarboxamides and pyridinecarboxamide compounds useful as Pim kinase inhibitorsINCYTE CORP·Filed 2014·Granted Dec 1, 2015·25 cites·24 claims
- 3996US9126948B2Pyrimidine-4,6-diamine derivatives as PI3K inhibitorsCOMBS ANDREW P·Filed 2012·Granted Sep 8, 2015·27 cites·31 claims
- 4096US8680108B2Substituted fused aryl and heteroaryl derivatives as PI3K inhibitorsLI YUN-LONG·Filed 2010·Granted Mar 25, 2014·62 cites·28 claims
- 4196US6967208B2Lactam-containing compounds and derivatives thereof as factor Xa inhibitorsBRISTOL MYERS SQUIBB PHARMA CO·Filed 2002·Granted Nov 22, 2005·100 cites·103 claims
- 4295US11905275B2Bipyrazole derivatives as JAK inhibitorsINCYTE CORP·Filed 2023·Granted Feb 20, 2024·2 cites·29 claims
- 4395US11433071B2Heterocyclylamines as PI3K inhibitorsINCYTE CORP·Filed 2020·Granted Sep 6, 2022·3 cites·20 claims
- 4495US10479803B2Bicyclic heteroarylaminoalkyl phenyl derivatives as PI3K inhibitorsINCYTE CORP·Filed 2018·Granted Nov 19, 2019·12 cites·52 claims
- 4595US10428087B2Pyrimidinones as PI3K inhibitorsINCYTE CORP·Filed 2018·Granted Oct 1, 2019·13 cites·39 claims
- 4695US9975907B2Pyrimidinones as PI3K inhibitorsINCYTE CORP·Filed 2016·Granted May 22, 2018·14 cites·51 claims
- 4795US9944645B2Imidazotriazines and imidazopyrimidines as kinase inhibitorsINCYTE HOLDINGS CORP·Filed 2016·Granted Apr 17, 2018·15 cites·15 claims
- 4895US9840503B2Heterocyclic compounds and uses thereofINCYTE CORP·Filed 2016·Granted Dec 12, 2017·15 cites·28 claims
- 4994US11819505B2Heterocyclylamines as PI3K inhibitorsINCYTE CORP·Filed 2022·Granted Nov 21, 2023·1 cites·6 claims
- 5094US11130767B2Bicyclic heteroarylaminoalkyl phenyl derivatives as PI3K inhibitorsINCYTE CORP·Filed 2019·Granted Sep 28, 2021·5 cites·20 claims
Showing the top 50 of 134 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Yun-Long Li files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →